Vendor profile
SERB SA
BE- Awards
- 6
- Total awarded value
- €2,250,001
- Countries
- Germany, Finland
- Latest award
- Jul 8, 2026
- Expiring within 12 months
- 1
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 07/08/2026 | DAK-Gesundheit | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate) | Pharmaceuticals | €1.0 | DE | — | View on TED ↗ |
| 04/15/2025 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 | — | — | DE | 06/30/2026 | View on TED ↗ |
| 04/15/2025 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 | — | — | DE | 06/30/2027 | View on TED ↗ |
| 07/15/2024 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Juli 2024 | — | — | DE | 06/30/2025 | View on TED ↗ |
| 07/15/2024 | PBMG eG | Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Juli 2024 | — | — | DE | 06/30/2025 | View on TED ↗ |
| 05/06/2024 | Terveyden ja hyvinvoinnin laitos | Finland – Various medicinal products – Hydroxocobalamin | — | €2.3M | FI | — | View on TED ↗ |